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-The Immunolymphatic Theory of Chronic Rejection 
AJ. Demetris, N. Murase, J.J. Fung, and T.E. Starzl 
CHRONIC rejection (CR) primarily manifests itself as a progressive obliterative arteriopathy (OA) that most 
frequently affects medium-sized muscular arteries of vascu-
larized organ allografts. The lack of similar changes in 
isografts argues strongly for an immunologic basis. The 
most widely accepted hypothesis proposed to explain CR 
suggests that direct immunologic injury to the graft endo-
thelium mediated by alloreactive cells and/Or antibodies 
triggers a vascular wall repair response driven by cytokines 
and growth factors. It will be referred to here as the "direct 
injury" modeL This response can be made worse by hyper-
lipidemia or ameliorated by drugs that block the immuno-
logic insult or the vessel wall response. 
Despite successful application of this line of reasoning. 
several morphologic observations on failed allografts with 
CR are not readily explained by the direct injury model, as 
illustrated by the following examples: (1) OA preferentially 
involves medium-sized muscular arteries with accentuation 
of the changes near first and second order branch points; 
(2) OA changes are less severe in smaller arteries and veins. 
despite an antigenically similar endothelium: (3) OA is not 
a complication of graft-versus-host disease. despite being an 
immunologic mirror image of rejection: (4) OA is not 
always preceded by intimal inflammation or endothelial 
disruption detectable by light microscopy; (5) mechanical 
factors in medium-sized arteries are not conducive to 
lymphocyte attachment and exocytosis, except during se-
vere immunologic reactions; (6) the reasons for an antigen-
dependent and antigen-independent phases of OA are not 
readily apparent. Many of these peculiarities suggest that 
mechanical factors also contribute to the development of 
OA. Moreover. the direct injury model does not address the 
immunopathogenic mechanisms responsible for the persis-
tent immunologic injury. 
An effort has been made in recent years by our group to 
reconcile these inconsistencies in clinical tissue samples and 
a small animal model of CR, which was inadvertently 
uncovered while conducting experiments on the significance 
of microchimerism.1.2 In that model, Brown-Norway (BN) 
rats are pretreated with a Lewis (LEW) bone marrow (BM) 
infusion or an orthotopic liver allograft (OL T) and a short. 
2-week course of immunosuppression with Tacrolimus:' 
These pretreated recipients arc then challenged 100 davs 
later with a heterotopic LEW heart allograft without im· 
munosuppression. 
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The heart grafts in both groups undergo a transient acute 
rejection between 5 and 15 days. marked by an influx of 
inflammation and an upregulation of both Th 1- and Th2-
type cytokine mRNA as detected by RT-PCR. Although all 
of the rats are operationally tolerant. in that the heart 
allografts are accepted and are beating for 100 days:' 
progressive CR and OA develop by 60 to 100 days in thc 
challenge heart grafts of BM-pretreated recipients but not 
in those conditioned with OL T. 
The development of CR and OA in the BM-pretreated 
group is associated with persistent low-grade inflammation 
and altered leukocyte trafficking through the heart allograft. 
loss of hematolymphoid chimerism. and focal disruption of 
microvascular and larger caliber lymphatic channels:' Free-
dom from CR in the OLT-pretreated group is associated 
with the persistence of donor MHC class II + hematolym-
phoid cells (microchimerism), including OX62+ donor den-
dritic cells, which are thought to be deleterious to graft 
survival. 
Histopathologic examination of the cardiac allografts in 
both groups showed successive stages in the development of 
OA. The early phase was seen in both groups and charac-
terized by arterial adventitial and interstitial mononuclear 
inflammation. edema, focal disruption of lymphatic chan-
nels, segmental medial degeneration of arteries. and the 
onset of medial myocyte proliferation.3 A slight increase in 
medial myocyte proliferation was also seen in isograft 
controls during the same time. but the magnitude was 
significantly less than in the allografts.] All of these changes 
occurred in the absence of intimal inflammation and an 
intact, but hypertrophied endothelium and resulted in mild 
intimal thickening in the OL T group by 60 days. which was 
not progressive at 100 days. These observations suggest that 
factor(s) associated with acute rejection. other than direct 
damage to the endothelium can contribute to the develop-
ment of OA. 
In contrast. the later phase of OA developed only in the 
BM-pretreated group. It was characterized by moderate to 
severe OA by 60 days that progressed by 100 days:' The 
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progressive changes were characterized by a marked in-
crease in myointimal proliferation. and adventitial. medial. 
and intimal inflammation-some of which appeared to 
invade in an "outside-in" fashion from the adventitia. There 
were also nodular aggregates of endocardial and adventitial 
inflammation that localized near draining lymphatics. 
Examination of a series of human liver allografts that 
failed at progressively longer periods of time after trans-
plantation revealed that arteriopathic changes were most 
common in medium-sized muscular arteries contained 
within the liver hilum. During acute rejection, some of the 
earliest arterial changes were similar to those seen in the 
above animal model, which include focal medial myocyte 
degeneration, medial edema, and endothelial cell hypertro-
phy. These changes appear to be followed by infiltration of 
macrophages into the media, apparently from the adventi-
tia. and then accumulation of foam cells in the subendothe-
lial space. Eventually, the foam cells are replaced by a 
subendothelial band of donor myofibroblasts, which is 
largely devoid of inflammation. However, the foam cells 
often persist in the deep intima, focally disrupt the media, 
and cuff the adventitia. 
Taken together, these observations suggest that a major 
driving force for arterial wall remodeling and the develop-
ment of OA appears early after transplantation and affects 
the artery in a segmental distribution. We propose that 
focal disruption of lymphatic drainage is a key pathogenic 
factor and results in abnormal intraorgan fluid fluxes, as 
shown before.· In our experience. early changcs are seen in 
the media and adventitia of both isografts and allografts. 
are present in all layers, and arc more pronounced in 
allografts. This driving force can be ameliorated in allo-
grafts by the disappearance of inflammation and regrowth 
of lymphatics. However. it indolently progresses when 
chronic inflammation and fibrosis permancntly alter the 
lymphatic drainage bed. which in turn would alter leukocytc 
trallicking through the organ, regardless of the stimulus tor 
intlammation. In such an environment. arterial pulsation 
alone can likely drive the remodeling, which is made worse 
if the interstitial fluid wntains cytokines. 
Lymphatic obstruction alone without organ transplanta-
tion can result in aneriopathic changes including edema. 
medial degeneration. and adventitial tibrosis. This is fol-
lowed by a shift to anaerobic catabolism of carbohydrate 
;tnd im:rcascd lactate and glycosaminc content in the vessel 
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wall, eventually producing decreased distensibility and 
greater elastic stiffness.s Studies done long ago have shown 
that lymphatics from a renal allograft eventually reconnect 
to recipient lymph vessels within 10 to 14 days,t' unless 
retarded by corticosteroid therapy or disrupted by rejec-
tion.3 .6 -1< During acute rejection. there is an increased 
production of lymph fluid and disruption of the lymphatic 
microvascular endothelial junctions, which retards lym-
phatic flow."-H The same is true of recurrent6 or late 
rejection episodes: Ruggiero et al9 showed total cessation of 
lymph flow from late-rejecting lung allografts. 
It is not our intention to discount the notion that direct 
intimal arterial injury can lead to OA: this clearly occurs 
with intense immunologic injury. Instead, complementary 
pathways are suggested that may be more common than 
previously realized. Moreover. this hypothesis incorporates 
both immunologic and mechanical factors into the patho-
genetic scheme. 
Last. the persistence of donor hematolymphoid cells in 
long-term recipients is associated with freedom from pro-
gressive CR. Our conclusion at this time is that the robust 
"tolerogenic" state induced by OLT is a result of the 
hematolymphoid chimerism. However. the liver could also 
apply other selection pressures to the recipient T-cell 
repertoire that could ameliorate the graft inflammation. 
Thus, our studies suggest a possible mechanism underlying 
the persistent immunologic injury and a reason for the 
association between immunologic injury and the develop-
ment of OA. other than direct endothelial injury. 
REFERENCES 
1. Murase N. Starzl TE. Tanabe M. ct al: Transplantation 
1I0:IS8.IYYS 
2. Starzl TE. Dcmetris AJ: lAMA 273:876. IYYS 
3. Demetris AJ. Murase N. Yc O. et al: Am J Pathol 150:S63. 
19l)7 
... Kline II'.. Thomas PA: Ann Thorae Surg 21:532, IY76 
5. Solti F. Jcllinck H. Schneider F. ct al: Lymphology 24:54. llJlJl 
6. Malek P. Vrubcl J. Kolc l: Bull Soc Internat Chirurgie 28: 110. 
IY69 
7. Coekctt AT. Sakai A. Netto IC: Trans Am Assoe Gcnito 
Urinary Surg 115:7.1. 1')73 
~K Eliska O. Eliskova M. Mircjovsky P: Nephron 44: 136. llJ86 
9. RUl!l!lero R. Fietsam R Jr. Thomas GA. ct al: J Thorae 
Cardiov;~;e Surg 108:253. 1')'14 
